METOO FILL+ LIGHT with Lidocaine

METOO FILL+ LIGHT with Lidocaine

METOO FILL+ LIGHT is a cross-linked hyaluronic acid dermal filler from Maypharm, South Korea. It is the softest gel in the METOO FILL+ range, with the smallest particle size, and is designed for fine, superficial lines. It contains 0.3% lidocaine to improve comfort during injection. Each box contains one 1.1 ml pre-filled syringe with 30G needle(s). For use by licensed physicians only.

Key Features

• Designed for Fine Lines: The softest gel in the range, with the smallest particles, intended for superficial placement.
• Cross-Linked Hyaluronic Acid: 24 mg/ml. According to the manufacturer, the gel is produced with a multi-stage cross-linking process followed by multi-step purification.
• With 0.3% Lidocaine: Helps reduce discomfort during injection.
• Reversible: Hyaluronic acid can be dissolved with hyaluronidase by a qualified practitioner.

The METOO FILL+ Range

The METOO FILL+ range includes fillers with different gel firmness. All have the same hyaluronic acid concentration. The physician selects the product according to the treatment area and tissue depth.

• METOO FILL+ LIGHT: The softest gel, for fine lines, injected superficially.
• METOO FILL+ DEEP: Medium firmness, for moderate to deep wrinkles, folds and lips, injected into the mid-to-deep dermis.
• METOO FILL+ VOLUME: The firmest gel, for volume and contour, injected deep.

Intended Use

• Fine, superficial lines
• Crow’s feet (lateral canthal lines)
• Fine perioral lines

Treatment area, injection depth, technique and volume must follow the official Instructions for Use and the treating physician’s assessment. Results and duration vary between individuals.

Product Specifications

• Brand: METOO
• Product: METOO FILL+ LIGHT (with lidocaine)
• Company: Maypharm Co., Ltd.
• Origin: South Korea
• Composition: Cross-linked hyaluronic acid 24 mg/ml, lidocaine hydrochloride 0.3%
• Injection Depth: Superficial to mid dermis, as specified in the IFU
• Contents: 1 × 1.1 ml pre-filled syringe, 30G needle(s)
• Shelf Life: Refer to the carton for the expiry date.
• Product Type: Hyaluronic acid dermal filler (medical device)

Administration

• For use only by licensed physicians trained in facial anatomy, superficial filler injection techniques and the management of filler complications.
• Check that the packaging is intact and the product is within its expiry date before use.
• Inject under aseptic conditions at the depth specified in the IFU. Inject slowly in small amounts with low pressure. Placement that is too superficial may cause visible bluish discoloration (Tyndall effect).
• Not intended for volume restoration, contouring or lip augmentation. Other products in the range are designed for these indications.
• Confirm the patient has no allergy to lidocaine or other amide-type local anaesthetics before use.
• Each syringe is for a single patient. Injection technique, volume and treatment interval must follow the IFU and the treating physician’s judgment.
• Do not self-administer.

Contraindications

General contraindications for hyaluronic acid fillers containing lidocaine are listed below. Refer to the official Instructions for Use for the complete list.

• Known hypersensitivity to hyaluronic acid, lidocaine or other amide-type local anaesthetics
• History of severe allergies or anaphylaxis
• Active infection, inflammation, wounds or skin disease at or near the injection site
• Pregnancy or breastfeeding
• Persons under 18 years of age

Who Should Consult a Physician First

• People with autoimmune disease, diabetes or epilepsy
• People with bleeding disorders or taking anticoagulant or antiplatelet medication
• People with a tendency to hypertrophic scars or keloids
• People with heart rhythm disorders, severe liver disease or porphyria
• People with permanent fillers, threads or implants in the treatment area
• People with a history of cold sores (herpes labialis), especially before perioral treatment
• People who have recently had laser, chemical peel or other resurfacing treatment in the area

Precautions

• Common reactions include redness, swelling, pain, tenderness, itching and bruising at the injection site.
• Lumps, nodules, visible product, bluish discoloration (Tyndall effect), infection and delayed inflammatory reactions may occur, particularly in thin skin.
• Accidental injection into a blood vessel can cause vascular occlusion, skin necrosis and, rarely, visual impairment or blindness. The area around the eye (vessels connected to the ophthalmic artery system) and the perioral area (superior and inferior labial arteries) require particular care.
• Hyaluronic acid can be dissolved with hyaluronidase. Practitioners should keep hyaluronidase and an emergency protocol available.
• Seek medical attention immediately for severe or increasing pain, skin blanching or colour change, or any change in vision after treatment.
• Do not use if the packaging is open or damaged, the syringe is cracked or the product is past its expiry date.
• Single use only. One syringe, one patient. Do not re-sterilise. Keep out of reach of children.

After Treatment

Follow the aftercare instructions given by the treating physician. Strenuous exercise, heat exposure, make-up and pressure or massage on the treated area are generally avoided for the first 24 hours, unless the physician advises otherwise. Report any adverse reaction to the treating physician.

Storage

Store as indicated on the carton. Protect from direct sunlight and freezing. Refer to the carton for the expiry date.

Package Contents

• 1 × 1.1 ml pre-filled syringe of METOO FILL+ LIGHT
• 30G needle(s)
• Instructions for Use

Important Notice

For professional healthcare use only. This information is for general product reference. It does not replace medical advice, the official Instructions for Use or local regulations. This product is not intended to diagnose, treat, cure or prevent any disease. Results vary between individuals.